1991
DOI: 10.1016/s0002-9394(14)73706-7
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Current Practices in the Management of Ocular Toxoplasmosis

Search citation statements

Order By: Relevance

Paper Sections

Select...
105
13
7
2

Citation Types

1
41
0
4

Year Published

Range
1992
1992
2025
2025

Publication Types

Select...
95
24
5

Relationship

1
123

Authors

Journals

citations

Cited by 124 publications

(46 citation statements)
references

References 26 publications

1
41
0
4
Order By: Relevance
How this paper cites the one you are viewing
“…Pharmacokinetic data from the present study documented levels of drug in serum and a disposition of clindamycin comparable to those reported previously in more detailed studies of orally administered clindamycin in healthy cats (5,6). The effective dosage of clindamycin for the treatment of toxoplasmosis is not known, and the dosages used in the present study were derived from clinical recommendations for cats (8,37) and humans with toxoplasmosis (9,17,32,39,49) and pharmacokinetic studies with cats (5,6). Clindamycin has been shown to reduce mortality in a model of chronic toxoplasmic pneumonia in mice when it was used prophylactically, but it appears to be less effective when it is used to treat clinically apparent reactivation (19).…”
Section: Discussion
supporting
confidence: 80%